Form 4: Nexalin CFO Granted 100,000 Stock Options

Nexalin Technology's CFO, Justin Van Fleet, was granted 100,000 stock options at an exercise price of $0.83, exercisable immediately.

Summary

• Justin Van Fleet, the Chief Financial Officer (CFO) of Nexalin Technology, Inc., was granted 100,000 stock options.
• The stock options have an exercise price of $0.83 per share.
• The transaction date for this grant was December 19, 2025.
• The options are immediately exercisable as of December 19, 2025, and are set to expire on December 19, 2030.
• These options were granted under the company's 2023 Equity Incentive Plan.
• The grant is contingent on obtaining shareholder approval to increase the 2023 Equity Incentive Plan limit, as required by NASDAQ Rules.
• Following this transaction, Justin Van Fleet beneficially owns a total of 230,435 derivative securities.

Sentiment

Score: 6

Explanation: The grant of options to a key executive is generally a positive sign of alignment and retention, but the contingency of shareholder approval introduces a minor uncertainty.

Positives

• The grant of stock options to the CFO aligns management's financial incentives with the long-term interests of shareholders.
• The options are immediately exercisable, providing the CFO with immediate potential upside if the company's stock price appreciates above the exercise price.

Negatives

• The effectiveness of the option grant is subject to future shareholder approval to increase the 2023 Equity Incentive Plan limit, introducing a contingency.

Risks

• The grant of 100,000 stock options is subject to shareholder approval to increase the 2023 Equity Incentive Plan limit under NASDAQ Rules. Failure to obtain this approval could result in the grant being rescinded or modified.

Future Outlook

The grant of these options is contingent on future shareholder approval to increase the 2023 Equity Incentive Plan limit under NASDAQ Rules, indicating a potential future corporate action related to governance and equity compensation.

Management Comments

• "Granted under the 2023 Equity Incentive Plan, subject to Shareholder Approval to increase the Plan limit under NASDAQ Rules."

Industry Context

Executive compensation, particularly through equity grants like stock options, is a standard practice across various industries. It serves to incentivize management performance and align their interests with long-term shareholder value. The requirement for shareholder approval for increases in equity plan limits is a common corporate governance standard for publicly traded companies, ensuring compliance with exchange rules.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: Will be asked to vote on increasing the equity plan limit, which could lead to potential future dilution if options are exercised, but also benefits from increased management incentive and performance.
• Management (CFO): Receives a significant equity incentive, aligning personal wealth with the company's performance and long-term success.

Next Steps

• The company will seek shareholder approval to increase the 2023 Equity Incentive Plan limit under NASDAQ Rules.

Key Dates

Keywords

Nexalin Technology, NXL, Justin Van Fleet, CFO, Stock Options, Equity Incentive Plan, Form 4, Insider Transaction, Executive Compensation